Showing results (1501-1510 of 1,853) with videos related to

Sort By:
Pageof 186
JAMA Network Open|May 23, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized TrialsLeigh H Fisher, Jia Jin Kee, Albert Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|January 23, 2024
A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)Stephen R Walsh, Cynthia L Gay, Shelly T Karuna, et al.
The Lancet. Digital Health|July 14, 2022
Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort studySeul Kee Byeon, Anil K Madugundu, Kishore Garapati, et al.
International Journal of Cardiology|July 16, 2014
Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis, D A Healy, W A Khan, et al.
BMC Infectious Diseases|July 5, 2022
Characterisation of Staphylococci species from neonatal blood cultures in low- and middle-income countriesKirsty Sands, Maria J Carvalho, Owen B Spiller, et al.
Nature Nanotechnology|November 19, 2021
Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammationJacob W Myerson, Priyal N Patel, Kathryn M Rubey, et al.
The Journal of Clinical Investigation|February 14, 2023
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adultsKristen W Cohen, Andrew Fiore-Gartland, Stephen R Walsh, et al.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2022
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein VaccineGustavo H Dayan, Nadine Rouphael, Stephen R Walsh, et al.
BMC Immunology|February 18, 2025
Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people without HIVTariro D Chawana, Stephen R Walsh, Lynda Stranix-Chibanda, et al.
The Lancet. HIV|December 12, 2024
Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trialSrilatha Edupuganti, Christopher B Hurt, Kathryn E Stephenson, et al.
Pageof 186